Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?

Steroids

Volumn 72, Issue 4, 2007, Pages 335-341

  Mittal, Rama D ^a   Mishra, Dhruva K ^a   Thangaraj, K ^b   Singh, Rajender ^b   Mandhani, Anil ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Androgen receptor; Human glandular kallikrein; North Indian population; Prostate cancer; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; DNA; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; GENETIC POLYMORPHISM; GENOTYPE; GLEASON SCORE; HUMAN; HUMAN CELL; INDIA; KRUSKAL WALLIS TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; POPULATION RISK; PROBABILITY; PROSTATE BIOPSY; PROSTATE CANCER; RECEPTOR GENE; RISK ASSESSMENT; TUMOR GENE; UNNECESSARY PROCEDURE;

ADULT; AGED; AGED, 80 AND OVER; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RETROSPECTIVE STUDIES; TISSUE KALLIKREINS;

EID: 33947414899     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.12.004     Document Type: Article

References (26)

1. Sinha R., Anderson D.E., McDonald S.S., and Greenwald P. Cancer risk and diet in India. J Postgrad Med 49 (2003) 222-228
2. Rubin M.A., and De Marzo A.M. Molecular genetics of human prostate cancer. Mod Pathol 17 (2004) 380-388
3. Irvine R.A., Yu M.C., Ross R.K., and Coetzee G.A. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55 (1995) 1937-1940
4. Stanford J.L., Just J.J., Gibbs M., et al. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57 (1997) 1194-1198
5. Chen C., Lamharzi N., Weiss N.S., et al. Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomar Prev 11 (2002) 1033-1040
6. Liu J.H., Li H.W., Tong M., Li M., and Na Y.Q. Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer. Zhonghua Yi Xue Za Zhi 84 (2004) 364-368
7. Mononen N., Ikonen T., Autio V., et al. Androgen receptor CAG polymorphism and prostate cancer risk. Hum Genet 111 (2002) 166-171
8. Lu S., Tsai S.Y., and Tsai M.J. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res 57 (1997) 4511-4516
9. Xue W., Irvine R.A., Yu M.C., et al. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 60 (2000) 839-841
10. Webber M.M., Waghray A., and Bello D. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1 (1995) 1089-1094
11. Herrala A., Kurkela R., Porvari K., et al. Human prostate-specific glandular kallikrein is expressed as an active and an inactive protein. Clin Chem 43 (1997) 279-284
12. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16 (1988) 1215
13. Binnie M.C., Alexander F.E., Heald C., and Habib F.K. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate 63 (2005) 309-315
14. Chiang C.H., Hong C.J., Chang Y.H., Chang L.S., and Chen K.K. Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer. J Urol 173 (2005) 429-432
15. Gsur A., Preyer M., Haidinger G., et al. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 23 (2002) 1647-1651
16. Coetzee G.A., and Ross R.K. Re: prostate cancer and the androgen receptor. J Natl Cancer Inst 86 (1994) 872-873
17. Cicek M.S., Conti D.V., Curran A., et al. Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR. Prostate 59 (2004) 69-76
18. Salinas C.A., Austin M.A., Ostrander E.O., and Stanford J.L. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 65 (2005) 58-65
19. Cicek M.S., Liu X., Casey G., and Witte J.S. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness. Cancer Epidemiol Biomar Prev 14 (2005) 2173-2177
20. Chiang C.H., Chen K.K., Chang L.S., and Hong C.J. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer. J Urol 171 (2004) 1529-1532
21. Darson M.F., Pacelli A., Roche P., et al. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49 (1997) 857-862
22. Nam R.K., Zhang W.W., Trachtenberg J., et al. Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection. J Clin Oncol 21 (2003) 2312-2319
23. Schatzl G., Marberger M., Remzi M., et al. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer. Urology 65 (2005) 1141-1145
24. Cohen P., Peehl D.M., Graves H.C., and Rosenfeld R.G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol 142 (1994) 407-415
25. Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
26. Xue W.M., Coetzee G.A., Ross R.K., et al. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomar Prev 10 (2001) 575-579